On December 31, 2015, Regeneron Pharmaceuticals (REGN) had a market capitalization of $62.5B, based on 115.66M shares at a price of $540.55.
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
December 2015 | $540.55 | 12,981,500 | 115,664,900 | $62,522,962,423.74 |
November 2015 | $542.18 | 15,062,800 | 115,664,900 | $62,710,698,122.93 |
October 2015 | $555.01 | 19,779,700 | 115,664,900 | $64,195,257,114.43 |
September 2015 | $463.15 | 20,759,500 | 115,944,000 | $53,699,985,348.00 |
August 2015 | $511.31 | 18,111,500 | 115,944,000 | $59,283,094,752.00 |
July 2015 | $551.30 | 13,328,200 | 115,944,000 | $63,919,532,990.40 |
June 2015 | $507.95 | 17,538,900 | 115,259,000 | $58,546,085,671.60 |
May 2015 | $510.37 | 15,383,600 | 115,259,000 | $58,824,966,348.00 |
April 2015 | $455.51 | 15,868,700 | 115,259,000 | $52,501,304,364.80 |
March 2015 | $449.55 | 21,053,400 | 115,183,300 | $51,780,975,028.24 |
February 2015 | $412.07 | 16,313,000 | 115,183,300 | $47,463,974,054.22 |
January 2015 | $414.88 | 17,185,100 | 115,183,300 | $47,787,408,760.62 |
December 2014 | $408.50 | 16,987,000 | 114,295,300 | $46,689,492,895.64 |
November 2014 | $414.33 | 15,016,100 | 114,295,300 | $47,356,394,541.61 |
October 2014 | $392.04 | 20,885,900 | 114,295,300 | $44,808,249,405.29 |
September 2014 | $358.98 | 16,774,200 | 117,423,000 | $42,152,625,963.00 |
August 2014 | $348.96 | 13,941,100 | 117,423,000 | $40,976,399,772.00 |
July 2014 | $314.87 | 19,959,800 | 117,423,000 | $36,973,003,494.60 |
June 2014 | $281.26 | 18,323,800 | 113,354,100 | $31,882,450,253.22 |
May 2014 | $305.65 | 15,361,600 | 113,354,100 | $34,646,646,658.77 |
April 2014 | $295.62 | 21,935,800 | 113,354,100 | $33,510,045,098.07 |
March 2014 | $299.00 | 27,725,200 | 112,151,000 | $33,532,947,128.20 |
February 2014 | $331.08 | 23,679,800 | 112,151,000 | $37,131,031,585.70 |
January 2014 | $287.36 | 19,504,800 | 112,151,000 | $32,227,498,273.10 |
December 2013 | $274.07 | 14,237,000 | 112,557,000 | $30,847,945,460.70 |
